Back to Search
J. MARSHALL, DMD
DMD
Endodontics
NPI: 1841413242Individual
Specialties, Licenses & Credentials
EndodonticsPrimary
Dentist — Endodontics
Code: 1223E0200X
9628(WA)
Research & Publications (20)
ISGIO and the Future of GI Oncology: A Very Different Society Making a Very Important Difference.
PMID 19343131·Gastrointest Cancer Res·2009
8-other
Health care reform: will we pass the external review?
PMID 19259325·Gastrointest Cancer Res·2008
8-other
Managing potentially resectable metastatic colon cancer.
PMID 19343144·Gastrointest Cancer Res·2008
8-other
Integrating targeted agents into therapeutic regimens for patients with resectable colorectal cancer.
PMID 19064409·Clin Colorectal Cancer·2008
6-review
Adjuvant Therapy for Stage II and III Colon Cancer: Consensus Report of the International Society of Gastrointestinal Oncology.
PMID 19262703·Gastrointest Cancer Res·2007
8-other
Restriction endonucleases that bridge and excise two recognition sites from DNA.
PMID 17266985·J Mol Biol·2007
8-other
Comparison of the diagnosis and management of unilaterally castrated and cryptorchid horses at a referral hospital: 60 cases (2002-2006).
PMID 17867979·J Am Vet Med Assoc·2007
4-observational
The development of novel agents for the treatment of colorectal cancer: a critical review of current practice and some suggestions for the future.
PMID 17519876·Clin Adv Hematol Oncol·2007
6-review
More fanfare for metastatic colon cancer resections.
PMID 19262700·Gastrointest Cancer Res·2007
8-other
The standard of care in oncology is unacceptable.
PMID 16841804·Oncology (Williston Park)·2006
8-other
Optimum use of biologics and role of maintenance therapy in colon cancer.
PMID 17178283·Semin Oncol·2006
6-review
Clinical implications of the mechanism of epidermal growth factor receptor inhibitors.
PMID 16909423·Cancer·2006
6-review
The impact of targeted therapy on the treatment of colorectal cancer.
PMID 16502666·Oncology (Williston Park)·2005
6-review
The role of bevacizumab as first-line therapy for colon cancer.
PMID 16399431·Semin Oncol·2005
6-review
Novel vaccines for the treatment of gastrointestinal cancers.
PMID 16396151·Oncology (Williston Park)·2005
4-observational
Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas.
PMID 15613691·J Clin Oncol·2005
3-trial
Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor.
PMID 15528978·Invest New Drugs·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5015 NE ST JOHNS RD
VANCOUVER, WA 98661 - Phone
- (360) 699-1101
Quick Facts
- NPI
- 1841413242
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile